Therefore, although further studies are warranted in order to explore additional mechanisms involved in the NAFLD regulation by FABP4, increasing evidence points out that FABP4 may regulate this disease through several mechanisms leading to JNK activation. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.